PDB9 Impact Of Ethnicity On The Efficacy And Safety Outcomes Of Anti-Diabetes Drugs – Case Study Of Liraglutide In Asian And Non-Asian Populations  by Chen, G et al.
A742  VA L U E  I N  H E A LT H  1 7  ( 2 0 1 4 )  A 7 1 9 – A 8 1 3  
PDB10
The Long-Term ouTcomes of BariaTric surgery on PaTienTs WiTh TyPe 
2 DiaBeTes meLLiTus: a sysTemaTic revieW anD meTa-anaLyses
Yu J, Li Y, Sun X, Zhou X, Tan J, Li S
West China Hospital, Sichuan University, Chengdu, China
Objectives: Bariatric surgery has been recommended as an effective treatment for 
overweight or obese patients with type 2 diabetes mellitus. The long-term follow up 
of such patients, however, has been limited. We performed a systematic review and 
meta-analyses to evaluate the long-term effect of bariatric surgery on patients with 
type 2 diabetes. MethOds: We searched PubMed, EMbase, and Cochrane Central 
Register of Controlled Trials up to September 2013. Trained reviewers, working in 
pairs, independently screened for eligible studies and extracted data. We pooled the 
data by using random-effects meta-analysis; qualitative description was applied 
for the data not available for pooling. We conducted pre-specified subgroup analy-
ses. Results: We included 25 studies (n= 23,628), consisting of 8 cohort studies with 
17407 patients (moderate or high risk of bias) and 17 non-controlled follow up stud-
ies with 6221 patients (high risk of bias). At baseline, the mean age of 48.5 years (69% 
were female), mean body mass index (BMI) was 45 kg/m2, 67% of patients received 
oral antidiabetic drug prior to surgery. 2.6% of patients (130/4950) died in the surgical 
group. Improvement on cardiovascular complications, nephropathy and quality of 
life was observed. BMI (-13.13 kg/m2[-17.66,-9.07]), Fasting Plasma Glucose (-59.74 
mg/dl [-74.59,-44.89]), and hemoglobin A1c (-1.83% [-2.4,-1.25]) declined significantly 
postoperatively. 67.1% of patients were in remission; diabetes was improved or 
resolved in 89.2% of patients. Subgroup analysis for alterative surgical procedures, 
length of follow up and the methods of data collection suggested no significant 
different. cOnclusiOns: Bariatric surgery should be considered as a long-lasting 
and effective treatment for patients with type 2 diabetes. However, our results are 
based on a small number studies with low quality, additional carefully designed 
studies on mortality, cardiovascular events and adverse events may provide further 
clarification.
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Objectives: To explore the impact of diabetes on mortality in inpatients from 
Medical Department in a Chinese tertiary hospital. MethOds: The data source 
was based on the electronic medical records (EMRs) database of West China 
Hospital. We collected diabetic and non-diabetic patients, in a ratio of 1:3,who 
were hospitalized from January 2009 to December 2012. The non-diabetic patients 
were chosen immediately after a diabetic patient was selected based on sequential 
unique hospitalized ID. Patients from medical department were chosen for analy-
sis. We collected information regarding patient demographics, diagnoses, prescrip-
tions, laboratory tests and health care resource utilization use. The ascertainment 
of diabetes and common co-morbidities (e.g.COPD) was based on ICD-10 code. 
Using in-hospital mortality as an outcome, we conducted multivariable logistic 
regression to explore the association of diabetes with mortality, after controlling 
for the influence of common co-morbidities of diabetes – which were considered 
important confounders - age, gender, smoking and alcohol use. Results: The 
retrospective analysis included a total of 32,052 patients with diabetes and 66,087 
patients without. The median ages were 66(IQR 56-74) and 52(IQR 39-65) in diabetic 
and non-diabetic group, respectively. And thus 19,659(61%) and 35,214(53%) were 
males, respectively. Multivariable logistic regression showed that patients with dia-
betes had an increased risk of mortality (adjusted odds ratio, AOR:1.17; 95%CI:1.03-
1.34) after controlling for common co-morbid conditions, including ischemic 
heart disease (AOR:1.56; 95%CI:1.32-1.85), chronic obstructive pulmonary disease 
(AOR:1.84; 95%CI: 1.55-2.19), kidney failure (AOR:4.75; 95%CI: 4.07-5.55), hepatic 
fibrosis and cirrhosis (AOR:4.02; 95%CI: 3.21-5.04), malignances (AOR:3.03; 95%CI: 
2.65-3.46) and depressive episode (AOR:1.82; 95%CI: 0.92-3.58). cOnclusiOns: 
Diabetes appears to be independently associated with increased risk of death in 
hospitalized patients in the medical departments. Nonetheless, this finding may 
be limited due to the control patient selection method (not randomly selected). 
Thus, the resulting association of diabetes and other co-morbid conditions with 
in-hospital death may be of limited generalizability.
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Objectives: To explore whether HES is independently associated with hospitalized 
mortality in ICU patients with diabetes from a Chinese tertiary hospital. MethOds: 
The retrospective cohort was from the electronic medical records (EMRs) database 
of West China Hospital from December 2010 to December 2012, which consisted of 
inpatients who were ever admitted in ICU department and had a discharge diagnosis 
of diabetes. Demographic characteristics, diagnoses, prescriptions, and laboratory 
tests were extracted. Ischemic heart diseases (IHD) and chronic renal failure (CRF) 
were extracted from discharging diagnoses according to ICD-10. High blood glucose 
was defined as the blood glucose higher than 7.8 mmol/L according to recommen-
dation from ENDO society when the patient was first admitted to hospital. Acute 
kidney injury (AKI) during hospitalization was defined as at least 1.5 fold increase 
of serum creatinine from baseline, according to KDIGO AKI guideline. Outcome vari-
able was the mortality during the hospitalization. Multivariate logistic regression 
model was used to explore the association of use of HES with mortality, adjusting 
for age, gender and above factors. Results: A total of 1,036 ICU patients with dia-
betes were identified in the database with a median age of 65(IQR 25-73) years old. 
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Objectives: To evaluate the prevalence of insulin injection-related lipohyper-
trophy (LH), a common complication of insulin therapy, associated risk factors, 
and to characterize the clinical and economic burdens of LH. Secondary objec-
tives will investigate the relationship between LH and HbA1c, total daily insulin 
dose, injection education, and reimbursement status among diabetic patients in 
China. MethOds: A descriptive, non-interventional, cross-sectional study was 
conducted among 400 diabetic patients from outpatient endocrinology depart-
ments in 4 cities, with and without insulin pen needle reimbursement. Eligible 
subjects were: ages 18-80, BMI ≥ 18.5 kg/m2, using insulin by pen injection currently 
and for ≥ one year continuously, with the ability to comprehend study procedures. 
Enrolled subjects 1) completed a questionnaire for socio-demographics, medical 
history, self-reported disease management as well as health resource utilization 
and work productivity, 2) underwent a structured physical examination, and 3) 
had HbA1c evaluated. The prevalence of LH was described by percentage and 
95% confidence interval. Logistic regression and log-linear analysis were applied 
to determine risk factors and the relationship between LH, HbA1c and insulin 
dose. Differences in insulin consumption and general health resource utilization 
were calculated between those with and without LH, and those with or without 
pen needle reimbursement. Results: Results expected: 1) Prevalence of insulin 
injection-related lipohypertrophy among patients in China using pen devices. 2) 
Risk factors for LH including socio-demographic characteristics, economic issues, 
and insulin injection-related factors. 3) Relationship between LH and HbA1c, hypo-
glycemia, and total daily insulin dose. 4) Economic burden of LH in the Chinese 
diabetes population. cOnclusiOns: Given the potential implications of LH for 
the diabetic population and for the Chinese health care system, we hope to bring 
awareness of the true magnitude of this condition.
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Objectives: Traditional medicines are valuable in management of chronic 
diseases like DM type 2. The Ayurvedic classical formulation Khadira kramuka 
kashaya(KKK) and Shilajatu(SHJ) are found to be clinically effective in DM type 
2. In this study, the clinical effect of the combination of formulations was stud-
ied. MethOds: The combined formulation (KKK+SHJ) was administered to 30 
patients whose base line data on blood sugar, HbA1C were recorded for 45 days. 
Apart from this, the patients feedback on urination frequency and quantity, 
Neuropathic symptoms, exhaustion, polydipsia, polyphagia, glycosuria and per-
spiration as per Ayurveda QOL were carried out once in 15 days . Results: the 
Mean for 30 patients FBS, PPBS (mg/dl) and HbA1C on day1, day 15, day 30 and 
day 45 were given in order. QOL data on day 1 and day 45 were given. The mean 
for 30 patients on FBS (mg/dl) on day1, day 15, day 45 - 136.2, 132.4, 30 129.5, 127.8; 
On PPBS (mg/dl) day1, day 15, day – 224.36, 223.62, 220.41, 218.83 ; HbA1C (%) on 
day1, day 15, day 45 – 7.84, 7.82, 7.79, 7.73. Overall assessment of Ayurveda QOL 
showed mild to moderate efficacy. cOnclusiOns: The classical combination of 
KKK and SHJ was found to be clinically effective along with improvement in QOL 
Ayurveda parameters.
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Objectives: Fuelled by dietary changes, increased sedentary lifestyles, and 
greater urbanisation in the Asia-Pacific region, there has been an increase in the 
number of people suffering from diabetes. Understanding the impact of ethnicity 
on the efficacy and safety of anti-diabetes drugs is necessary to optimise drug 
development strategies and shorten the time lag between drug approval in the 
West and in Asia. The purpose of this study was to examine the role of ethnicity 
on treatment outcomes in diabetes clinical trials, using liraglutide as an exam-
ple. MethOds: Targeted searches were performed in PubMed and clinicaltrials.
gov to identify relevant studies. To be included in our analysis the study had to: 
be a completed double-blind phase 3 clinical trial of liraglutide; include patients 
with type 2 diabetes and report Δ HbA1c as an outcome. The included studies were 
divided by population ethnicity, followed by subsequent extraction of relevant 
baseline characteristics and outcomes. Results: Nine Asian and eight non-Asian 
studies satisfied all inclusion criteria. Asian study populations tended to have a 
lower body mass index than their non-Asian comparators, which was reflected 
by the lower treatment dosages. Moreover, there was a trend towards longer 
duration of disease in Asians, although not statistically significant (p= 0.5636). 
Substantial heterogeneity was observed between the clinical trial designs, includ-
ing variable treatment durations, choice of comparator drugs, and the use of 
mono- or combination therapy. As a result, it was not possible to compare the 
clinical outcomes between Asian and non-Asian populations. cOnclusiOns: 
Clear differences between Asian and non-Asian studies highlight the need for 
improved standardisation of clinical trial designs to enable the investigation of 
the impact of ethnicity on efficacy and safety results from clinical trials. Further 
research into other drugs and disease areas is required to more fully understand 
this topic.
